Rani Therapeutics Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q2 2024 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q3 2024 | 2 | -$0.35 | -$0.15 | -$0.27 |
| Q1 2025 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q2 2025 | 1 | -$0.36 | -$0.36 | -$0.36 |
| Q3 2025 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q4 2025 | 1 | -$0.34 | -$0.34 | -$0.34 |
Rani Therapeutics Holdings, Inc. Earnings Date And Information
Rani Therapeutics Holdings, Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-0.26 earnings per share for the quarter, topping analysts' consensus estimates of $-0.29 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Rani Therapeutics Holdings, Inc. has generated $-1 earnings per share over the last year ($-1.33 diluted earnings per share) and currently has a price-to-earnings ratio of -2.1. Rani Therapeutics Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based on prior year's report dates.
Rani Therapeutics Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.24 | $0 | $0 | ||
| 08/06/2024 | Q2 2024 | -$0.29 | -$0.26 | 0.03 | $0 | $0 |
| 05/06/2024 | Q1 2024 | -$0.23 | -$0.29 | -0.06 | $0 | |
| 03/20/2024 | Q4 2023 | -$0.31 | -$0.27 | 0.04 | $2.75 M | |
| 11/08/2023 | Q3 2023 | -$0.47 | -$0.36 | 0.11 | $0 | |
| 08/11/2023 | Q2 2023 | -$0.40 | -$0.37 | 0.03 | $0 | |
| 05/10/2023 | Q1 2023 | -$0.47 | -$0.33 | 0.14 | $0 | |
| 03/22/2023 | Q4 2022 | -$0.26 | -$0.70 | -0.44 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.33 | -$0.66 | -0.33 | $130,000 | $0 |
| 08/10/2022 | Q2 2022 | -$0.28 | -$0.66 | -0.38 | $130,000 | $0 |
| 05/11/2022 | Q1 2022 | -$1.00 | -$0.65 | 0.35 | $0 | |
| 03/30/2022 | Q4 2021 | -$0.68 | $-2,717,000 | |||
| 11/15/2021 | Q3 2021 | -$0.16 | $630,000 | $0 | ||
| 09/13/2021 | Q2 2021 | -$0.18 | -$0.00 | 0.18 | $490,000 | $1.96 M |
| 03/30/2021 | Q1 2021 | -$0.30 | $756,000 | |||
| 12/30/2020 | Q4 2020 | -$0.89 | $210,000 | |||
| 09/29/2020 | Q3 2020 | -$0.15 | $108,000 | |||
| 06/29/2020 | Q2 2020 | -$0.14 | $60,000 | |||
| 03/30/2020 | Q1 2020 | -$0.29 | $83,000 |
Rani Therapeutics Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Rani Therapeutics Holdings, Inc.'s earnings date?
Rani Therapeutics Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off last year's report dates.
-
Did Rani Therapeutics Holdings, Inc. beat their earnings estimates last quarter?
In the previous quarter, Rani Therapeutics Holdings, Inc. (:RANI) reported $-0.26 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.29 by $0.03.
-
How can I listen to Rani Therapeutics Holdings, Inc.'s earnings conference call?
The conference call for Rani Therapeutics Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Rani Therapeutics Holdings, Inc.'s conference call transcript?
The conference call transcript for Rani Therapeutics Holdings, Inc.'s latest earnings report can be read online.
-
How much profit does Rani Therapeutics Holdings, Inc. generate each year?
Rani Therapeutics Holdings, Inc. (:RANI) has a recorded net income of $0. Rani Therapeutics Holdings, Inc. has generated $-1.33 earnings per share over the last four quarters.
-
What is Rani Therapeutics Holdings, Inc.'s price-to-earnings ratio?
Rani Therapeutics Holdings, Inc. (:RANI) has a price-to-earnings ratio of -2.1 and price/earnings-to-growth ratio is -0.21.
